`
`IPR2021-00972
`
`U.S. Patent No. 10,638,941
`PATENT OWNER’S MOTION TO EXCLUDE
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`________________
`
`APPLE, INC.,
`Petitioner,
`
`v.
`
`ALIVECOR, INC.,
`Patent Owner
`________________
`IPR2021-00972
`U.S. Patent No. 10,638,941
`________________
`
`PATENT OWNER’S MOTION TO EXCLUDE
`
`
`
`
`
`
`
`
`
`
`
`I.
`
`II.
`
`IPR2021-00972
`
`
`PATENT OWNER’S MOTION TO EXCLUDE
`
`TABLE OF CONTENTS
`
`Page
`
`INTRODUCTION ........................................................................................... 1
`
`ARGUMENTS ................................................................................................ 1
`
`A.
`
`B.
`
`Petitioner Offers Dr. Stultz’s Statements For Their Truth .................... 1
`
`No Hearsay Exception Applies ............................................................. 3
`
`III.
`
`PETITIONER’S NEW EVIDENCE SHOULD BE EXCLUDED ................. 5
`
`IV. CONCLUSION ................................................................................................ 5
`
`
`
`
`
`
`i
`
`
`
`
`I.
`
`INTRODUCTION
`
`IPR2021-00972
`
`
`PATENT OWNER’S MOTION TO EXCLUDE
`
`Pursuant to 37 C.F.R. §42.64 and the Federal Rules of Evidence, Patent
`
`Owner AliveCor Inc. (“AliveCor”) moves to exclude Exhibits 1081 (Stultz ITC
`
`expert report), 1082 (Stultz ITC deposition), 1083 (Stultz ITC demonstratives), and
`
`1072-1073 (Stultz ITC hearing testimony), all of which relate to a new expert, Dr.
`
`Stultz and other exhibits added on reply. Dr. Stultz is Apple’s expert in the co-
`
`pending ITC investigation, but has not given testimony in this proceeding. Despite
`
`this, Petitioner relies on Dr. Stultz’s hearsay testimony given in other proceedings.
`
`AliveCor timely objected to these exhibits on sufficiently particularized grounds.
`
`See Paper 30.
`
`Exhibits 1072-73; 1081-83 consist of statements made outside the course of
`
`this IPR proceeding that petitioner relies upon for their truth and are therefor hearsay.
`
`Further, no exception to the rules against hearsay apply here, thus those statements
`
`are inadmissible. In addition, both Dr. Stultz’s testimony and Exhibits 1060-68;
`
`1074-80; 1084-85 constitute new evidence that are not properly raised in Reply.
`
`Accordingly, AliveCor requests the Board exclude Exhibits 1060-68 and 1072-85.
`
`II. ARGUMENTS
`
`A.
`
`Petitioner Offers Dr. Stultz’s Statements For Their Truth
`
`Out-of-court statements offered for their truth are inadmissible hearsay. See
`
`FED. R. EVID. 801. Here, Petitioner offers for its truth out-of-court statements made
`
`
`
`1
`
`
`
`
`by Dr. Stultz in various documents, all of which relate to the co-pending ITC
`
`IPR2021-00972
`
`
`PATENT OWNER’S MOTION TO EXCLUDE
`
`investigation. Specifically, the exhibits at issue are Dr. Stultz’s ITC expert report
`
`(Ex. 1081), Dr. Stultz’s ITC deposition (Ex. 1082), Dr. Stultz’s hearing testimony
`
`(Ex. 1072-73), and demonstratives to Dr. Stultz’s ITC hearing testimony (Ex.
`
`1083).1
`
`Specifically, Petitioner relies on Dr. Stultz’s ITC testimony to support various
`
`positions regarding machine learning. See IPR2021-00970, Paper 30 at 182. This is
`
`likely because Petitioner’s IPR expert, Dr. Chaitman, made several critical
`
`admissions on this topic during his cross-examination – specifically, that he had no
`
`expertise whatsoever in machine learning or any engineering discipline. Ex. 2017
`
`8:4-19 (no engineering experience), 8:20-16 (no design experience) 27:23-28:1,
`
`108:6-109:24 (no experience with machine learning). These admissions leave
`
`
`1 While AliveCor also cited testimony from Dr. Stultz, in that instance the testimony
`
`was an admission of a party opponent and was therefore subject to an exception to
`
`the hearsay rule. See e.g., Response at 10; Ex. 2018 at 62. Accordingly, Petitioner
`
`did not object to those exhibits. Petitioner’s use of Dr. Stultz’s testimony, however,
`
`is hearsay subject to no exception.
`
`2 While Petitioner file these exhibits in this case, it fails to cite them in this action.
`
`See generally, Reply. These exhibits should be excluded for this reason alone.
`
`
`
`2
`
`
`
`
`Petitioner with no credible expert testimony on machine learning. Petitioner
`
`IPR2021-00972
`
`
`PATENT OWNER’S MOTION TO EXCLUDE
`
`attempts instead to rely on Dr. Stultz to support the propositions that: 1) “machine
`
`learning algorithm” is generic functional language (IPR2021-00970, Paper 30 at 18);
`
`2) “machine learning to detect arrhythmia based on heart rate parameters [] was well
`
`known” (Id.); and 3) to rebut that machine learning is not trusted by clinicians as a
`
`“black box” (id. at 19).
`
`B. No Hearsay Exception Applies
`
`Dr. Stultz’s statements in Exhibits 1072-73; 1081-83 are not subject to any
`
`hearsay exceptions.
`
`As an initial matter, Exhibits 1072-73; 1081-83 do not satisfy any of the
`
`conditions that are set forth in Rule 803. FED. R. EVID. 803. Dr. Stultz’s hearsay
`
`testimony, for example, is not a present sense impression (Rule 803(1)); an excited
`
`utterance (Rule 803(2)); a statement of his then-existing state of mind (Rule 803(3));
`
`a recorded recollection (Rule 803(5)); a record of a regularly conducted activity
`
`(Rule 803(6)); or a public record (Rule 803(10)). These are merely illustrative—no
`
`hearsay exception enumerated in Rule 803 applies to Dr. Stultz’s ITC testimony.
`
`Likewise, the Rule 804 exceptions do not apply because those exceptions all
`
`require a witness to be unavailable. Fed. R. Evid. 804. Under Rule 804, a witness
`
`is unavailable if: (1) due to a testifying exemption from court rules or privilege; (2)
`
`refusing to testify despite a court order; (3) lack of memory; (4) declarant death or
`
`
`
`3
`
`
`
`
`then-existing infirmity, physical illness, or mental illness; (5) or if the declarant’s
`
`IPR2021-00972
`
`
`PATENT OWNER’S MOTION TO EXCLUDE
`
`testimony is not obtainable by process or other reasonable means. Id. None of these
`
`circumstances applies here; rather, Petitioner has made no apparent effort to offer
`
`Dr. Stultz’s testimony in this proceeding. See CaptionCall, L.L.C. v. Ultratec, Inc.,
`
`IPR2015-00637 (Paper 98), at 15-16 (PTAB Sept. 7, 2016) (no attempt to bring
`
`forward out-of-court declarant as a witness undercuts applicability of Rule
`
`804(b)(1)).
`
`Rule 807 (the residual hearsay exception) does not apply either because it
`
`requires the statement to: (1) have equivalent circumstantial guarantees of
`
`trustworthiness; (2) be offered as evidence of a material fact; (3) be more probative
`
`on the point for which it is offered than any other evidence that the proponent can
`
`obtain through reasonable efforts; and (4) be in the interests of justice to admit. Fed.
`
`R. Evid. 807. The Board has held that the exercise of the residual exception “is to be
`
`reserved for ‘exceptional cases' and is not 'a broad license on trial judges to admit
`
`hearsay statements that do not fall within one of the other exceptions.’” Neste Oil
`
`OYJ v. REG Synthetic Fuels, LLC, IPR2013-00578 (Paper 52), at 9 (PTAB March
`
`12, 2015) (quoting Conoco, Inc. v. Dep’t of Energy, 99 F.3d 387, 392 (Fed. Cir.
`
`1996)). This is not an exceptional case at least because the interest of justice is not
`
`served when, as here, the Petitioner made no effort to procure Dr. Stultz’s statements
`
`in this proceeding. See CaptionCall, IPR2015-00637 (Paper 98), at 15-16.
`
`
`
`4
`
`
`
`
`Moreover, Petitioner has failed to demonstrate that Dr. Stultz’s statements are more
`
`IPR2021-00972
`
`
`PATENT OWNER’S MOTION TO EXCLUDE
`
`probative than other evidence it could have obtained through reasonable efforts. Id.
`
`at 16-17. Likewise the Board has already found the residual exception is
`
`inapplicable in similar outside expert situation. See GAF Materials LLC., v Kirsch
`
`Research and Development, LLC., PTAB-IPR2021-00192 (Paper 45), at 62-65.
`
`III. PETITIONER’S NEW EVIDENCE SHOULD BE EXCLUDED
`
`As the Board notes in its Trial Guide, “Petitioner may not submit new
`
`evidence or argument in reply that it could have presented earlier, e.g. to make out a
`
`prima facie case of unpatentability.” Patent Trial and Appeal Board Consolidated
`
`Trial Practice Guide (November 2019) at 73; 37 C.F.R. 42.64(c); see also Belden
`
`Inc v. Berk-Tek LLC, 805 F.3d 1064, 1081 (Fed. Cir. 2015). Exhibits 1060-68 and
`
`1072-85 are new secondary references and testimony by Dr. Stultz that Petitioner
`
`could have but did not present in its petition, and cannot be characterized as
`
`responsive arguments or evidence, and should be excluded now on reply.
`
`IV. CONCLUSION
`
`In view of the foregoing, AliveCor respectfully submits Exhibits 1060-68 and
`
`1072-85 should be excluded.
`
`
`
`Date: August 24, 2022
`
`
`
`
`
` By: /Jim Glass/
`James M. Glass (Reg. No. 46,729)
`QUINN EMANUEL URQUHART &
`
`SULLIVAN LLP
`
`
`
`5
`
`
`
`
`
`CERTIFICATE OF SERVICE (37 C.F.R. §§ 42.6(E), 42.105(A))
`
`IPR2021-00972
`
`
`PATENT OWNER’S MOTION TO EXCLUDE
`
`The undersigned hereby certifies that the foregoing document was served in
`
`its entirety on August 24, 2022 upon the following parties via Electronic Mail.
`
`W. Karl Renner Jeremy J. Monaldo
`
`IPR50095-0032IP1@fr.com
`
`PTABInbound@fr.com
`
`axf-ptab@fr.com
`
`monaldo@fr.com
`
`
`
`
`
`
`
`
`
`Date: August 24, 2022
`
` By: /Jim Glass/
`James M. Glass (Reg. No. 46,729)
`QUINN EMANUEL URQUHART &
`
`SULLIVAN LLP
`
`
`
`6
`
`